breast cancer and glp 1 drugs GLP-1 cut risk by 30%? Not so fast Video New study links GLP-1

Mauricio D, Gratacs M, Franch-Nadal J

Although cagrilintide-semaglutide produced greater weight loss than either monotherapy alone in REDEFINE 1, the study design does not permit a formal assessment of pharmacological additivity or synergy

Durable restoration of -cell function, reflected in sustained improvements in glycemic parameters, is associated with early weight reduction of 10% in the first years following T2D diagnosis (Morieri et al., 2025)

Accumulating evidence has revealed that gut dysbiosis causes a reduced ratio of Firmicutes/Bacteroidetes (F/B) in SLE patients (123)

If that is the case, a Vitamin B12 injection can help

Cancers 13 , 5500 (2021)